Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1107517

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach


Gelemanović, Andrea; Vidović, Tinka; Stepanić, Višnja; Trajković, Katarina
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach // Pharmaceuticals, 14 (2021), 2; 87, 17 doi:10.3390/ph14020087 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1107517 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach

Autori
Gelemanović, Andrea ; Vidović, Tinka ; Stepanić, Višnja ; Trajković, Katarina

Izvornik
Pharmaceuticals (1424-8247) 14 (2021), 2; 87, 17

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
drug repurposing ; connectivity map ; COVID-19 ; SARS-CoV-2 ; host transcriptome

Sažetak
A year after the initial outbreak, the COVID-19 pandemic caused by SARS-CoV-2 virus remains a serious threat to global health, while current treatment options are insufficient to bring major improvements. The aim of this study is to identify repurposable drug candidates with a potential to reverse transcriptomic alterations in the host cells infected by SARS-CoV-2. We have developed a rational computational pipeline to filter publicly available transcriptomic datasets of SARS-CoV-2-infected biosamples based on their responsiveness to the virus, to generate a list of relevant differentially expressed genes, and to identify drug candidates for repurposing using LINCS connectivity map. Pathway enrichment analysis was performed to place the results into biological context. We identified 37 structurally heterogeneous drug candidates and revealed several biological processes as druggable pathways. These pathways include metabolic and biosynthetic processes, cellular developmental processes, immune response and signaling pathways, with steroid metabolic process being targeted by half of the drug candidates. The pipeline developed in this study integrates biological knowledge with rational study design and can be adapted for future more comprehensive studies. Our findings support further investigations of some drugs currently in clinical trials, such as itraconazole and imatinib, and suggest 31 previously unexplored drugs as treatment options for COVID- 19.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija, Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Farmacija



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb,
Mediteranski institut za istraživanje života

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com fulir.irb.hr

Citiraj ovu publikaciju:

Gelemanović, Andrea; Vidović, Tinka; Stepanić, Višnja; Trajković, Katarina
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach // Pharmaceuticals, 14 (2021), 2; 87, 17 doi:10.3390/ph14020087 (međunarodna recenzija, članak, znanstveni)
Gelemanović, A., Vidović, T., Stepanić, V. & Trajković, K. (2021) Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach. Pharmaceuticals, 14 (2), 87, 17 doi:10.3390/ph14020087.
@article{article, author = {Gelemanovi\'{c}, Andrea and Vidovi\'{c}, Tinka and Stepani\'{c}, Vi\v{s}nja and Trajkovi\'{c}, Katarina}, year = {2021}, pages = {17}, DOI = {10.3390/ph14020087}, chapter = {87}, keywords = {drug repurposing, connectivity map, COVID-19, SARS-CoV-2, host transcriptome}, journal = {Pharmaceuticals}, doi = {10.3390/ph14020087}, volume = {14}, number = {2}, issn = {1424-8247}, title = {Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach}, keyword = {drug repurposing, connectivity map, COVID-19, SARS-CoV-2, host transcriptome}, chapternumber = {87} }
@article{article, author = {Gelemanovi\'{c}, Andrea and Vidovi\'{c}, Tinka and Stepani\'{c}, Vi\v{s}nja and Trajkovi\'{c}, Katarina}, year = {2021}, pages = {17}, DOI = {10.3390/ph14020087}, chapter = {87}, keywords = {drug repurposing, connectivity map, COVID-19, SARS-CoV-2, host transcriptome}, journal = {Pharmaceuticals}, doi = {10.3390/ph14020087}, volume = {14}, number = {2}, issn = {1424-8247}, title = {Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach}, keyword = {drug repurposing, connectivity map, COVID-19, SARS-CoV-2, host transcriptome}, chapternumber = {87} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font